Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming
Glucose is the main circulating energy substrate for the adult brain. Owing to the high energy demand of nerve cells, glucose is actively oxidized to produce ATP and has a synergistic effect with mitochondria in metabolic pathways. The dysfunction of glucose metabolism inevitably disturbs the normal...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/11/5887 |
_version_ | 1797531953278222336 |
---|---|
author | Rongrong Han Jing Liang Bing Zhou |
author_facet | Rongrong Han Jing Liang Bing Zhou |
author_sort | Rongrong Han |
collection | DOAJ |
description | Glucose is the main circulating energy substrate for the adult brain. Owing to the high energy demand of nerve cells, glucose is actively oxidized to produce ATP and has a synergistic effect with mitochondria in metabolic pathways. The dysfunction of glucose metabolism inevitably disturbs the normal functioning of neurons, which is widely observed in neurodegenerative disease. Understanding the mechanisms of metabolic adaptation during disease progression has become a major focus of research, and interventions in these processes may relieve the neurons from degenerative stress. In this review, we highlight evidence of mitochondrial dysfunction, decreased glucose uptake, and diminished glucose metabolism in different neurodegeneration models such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD). We also discuss how hypoxia, a metabolic reprogramming strategy linked to glucose metabolism in tumor cells and normal brain cells, and summarize the evidence for hypoxia as a putative therapy for general neurodegenerative disease. |
first_indexed | 2024-03-10T10:52:09Z |
format | Article |
id | doaj.art-e09ad5c6040e49c186754fcb46d9cae0 |
institution | Directory Open Access Journal |
issn | 1661-6596 1422-0067 |
language | English |
last_indexed | 2024-03-10T10:52:09Z |
publishDate | 2021-05-01 |
publisher | MDPI AG |
record_format | Article |
series | International Journal of Molecular Sciences |
spelling | doaj.art-e09ad5c6040e49c186754fcb46d9cae02023-11-21T22:09:08ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-05-012211588710.3390/ijms22115887Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic ReprogrammingRongrong Han0Jing Liang1Bing Zhou2Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Interdisciplinary Innovation Institute of Medicine and Engineering, Beihang University, Beijing 100191, ChinaBeijing Advanced Innovation Center for Big Data-Based Precision Medicine, Interdisciplinary Innovation Institute of Medicine and Engineering, Beihang University, Beijing 100191, ChinaBeijing Advanced Innovation Center for Big Data-Based Precision Medicine, Interdisciplinary Innovation Institute of Medicine and Engineering, Beihang University, Beijing 100191, ChinaGlucose is the main circulating energy substrate for the adult brain. Owing to the high energy demand of nerve cells, glucose is actively oxidized to produce ATP and has a synergistic effect with mitochondria in metabolic pathways. The dysfunction of glucose metabolism inevitably disturbs the normal functioning of neurons, which is widely observed in neurodegenerative disease. Understanding the mechanisms of metabolic adaptation during disease progression has become a major focus of research, and interventions in these processes may relieve the neurons from degenerative stress. In this review, we highlight evidence of mitochondrial dysfunction, decreased glucose uptake, and diminished glucose metabolism in different neurodegeneration models such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD). We also discuss how hypoxia, a metabolic reprogramming strategy linked to glucose metabolism in tumor cells and normal brain cells, and summarize the evidence for hypoxia as a putative therapy for general neurodegenerative disease.https://www.mdpi.com/1422-0067/22/11/5887brain energy metabolismglucoseneurodegenerative diseasehypoxiametabolic reprogramming |
spellingShingle | Rongrong Han Jing Liang Bing Zhou Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming International Journal of Molecular Sciences brain energy metabolism glucose neurodegenerative disease hypoxia metabolic reprogramming |
title | Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming |
title_full | Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming |
title_fullStr | Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming |
title_full_unstemmed | Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming |
title_short | Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming |
title_sort | glucose metabolic dysfunction in neurodegenerative diseases new mechanistic insights and the potential of hypoxia as a prospective therapy targeting metabolic reprogramming |
topic | brain energy metabolism glucose neurodegenerative disease hypoxia metabolic reprogramming |
url | https://www.mdpi.com/1422-0067/22/11/5887 |
work_keys_str_mv | AT rongronghan glucosemetabolicdysfunctioninneurodegenerativediseasesnewmechanisticinsightsandthepotentialofhypoxiaasaprospectivetherapytargetingmetabolicreprogramming AT jingliang glucosemetabolicdysfunctioninneurodegenerativediseasesnewmechanisticinsightsandthepotentialofhypoxiaasaprospectivetherapytargetingmetabolicreprogramming AT bingzhou glucosemetabolicdysfunctioninneurodegenerativediseasesnewmechanisticinsightsandthepotentialofhypoxiaasaprospectivetherapytargetingmetabolicreprogramming |